Skip to main content
Clinical Cardiology logoLink to Clinical Cardiology
. 2009 Feb 3;20(3):213–218. doi: 10.1002/clc.4960200306

Predictive value of dobutamine radionuclide ventriculography in detection of functional improvement after acute anterior wall infarction and thrombolytic therapy

Nili Zafrir 1,, Roni Bassevich 1, Bruria Zlotikamien 1, Jaqueline Sulkes 1, Shmuel Sclarovsky 1, Ernesto Lubin 1
PMCID: PMC6656290  PMID: 9068905

Abstract

Background: Prolonged postischemic ventricular dysfunction (stunned myocardium) may prevent the assessment of myocardial salvage early after thrombolysis. Dobutamine in conjunction with radionuclide ventriculography has been proposed for the early assessment of myocardial viability and prediction of functional recovery.

Hypothesis: This study was designed to investigate the effects of low‐dose dobutamine infusion on early global and regional function of reperfused myocardium after acute anterior wall myocardial infarction (MI). In particular, our purpose was to examine whether this response can predict late recovery of left ventricular function and correlate with the reperfused status (patency of infarct‐related artery).

Methods: In all, 29 consecutive patients with first uncomplicated anterior wall MI, and who had received thrombolytic therapy, underwent radionuclide ventriculography at rest and 2 min after each dose increment of dobutamine infusion (5–15 m̈g/kg/min) on the third day after the infarction, at discharge, and at 3 months' follow‐up. Global and regional ejection fraction were calculated at each stage. Four patients with complications were dropped from the study. A significant response to dobutamine was defined as an increase of at least ≥7% in global or regional ejection fraction at the infarct zones.

Results: Of the 25 patients, 18 (72%) fulfilled these criteria. Of these, 10 patients (56%) had a significant improvement in global or regional ejection fraction at discharge and 13 patients (72%) at 3‐month follow‐up. The overall sensitivity of the dobutamine test in predicting left ventricular improvement was 100% at discharge and 93% at 3‐month follow‐up. However, the positive and negative predictive values were 56 and 100% at discharge and 72 and 86%, respectively, at 3‐month follow‐up.

Conclusion: Low‐dose dobutamine radionuclide ventriculography is a safe and useful test for assessing myocardial viability and may predict late functional improvement in patients with anterior wall MI.

Keywords: dobutamine, radionuclide ventriculography, acute anterior wall infarction, functional improvement

Full Text

The Full Text of this article is available as a PDF (632.9 KB).

References

  • 1. Corady E, Meerbaum S: Symposium on the present status of reperfusion of the acutely ischemic myocardium. Part 1. J Am Coll Cardiol 1983; 1: 1031–1122. [DOI] [PubMed] [Google Scholar]
  • 2. Reimer KA, Lowe JE, Rasmussen MM, Jennys RB: The wavefront phenomenon of ischemic cell death. Myocardial infarct size vs. duration of coronary occlusion in dogs. Circulation 1977; 56: 786–794. [DOI] [PubMed] [Google Scholar]
  • 3. Costanitini C, Corady E, Lange T: Revascularization after three hours of coronary artery occlusion. Effects on regional cardiac metabolic function and infarct size. Am J Cardiol 1975; 36: 368–384. [DOI] [PubMed] [Google Scholar]
  • 4. Ellis SG, Henschke CI, Sandon T, Wynne J, Braunwald E, Kloner RA: Time course of functional and biochemical recovery of myocardium salvages by reperfusion. J Am Coll Cardiol 1983; 1: 1047–1055. [DOI] [PubMed] [Google Scholar]
  • 5. Braunwald E, Kloner RA: The stunned myocardium—prolonged, post‐ischemic ventricular dysfunction. Circulation 1982; 66: 1146–1149. [DOI] [PubMed] [Google Scholar]
  • 6. Ellis SG, Wynne J, Braunwald E, Henschke CI, Sandon T, Kloner RA: Response of reperfusion‐salvaged stunned myocardium to inotropic stimulation. Am Heart J 1984; 107: 13–19. [DOI] [PubMed] [Google Scholar]
  • 7. Bolli R, Tho WX, Myers MZ, Heartley CJ, Roberts R: Beta‐adrenergic stimulation reverses post‐ischemic myocardial dysfunction without producing subsequent functional deterioration. Am J Cardiol 1985; 56: 964–968. [DOI] [PubMed] [Google Scholar]
  • 8. Becker RC, Levine JH, DiPaula AF, Guarnieri T, Aversano T: Reversal of dysfunction in post ischemic stunned myocardium by epinephrine and postextrasystolic potentiation. J Am Coll Cardiol 1986; 7: 580–589. [DOI] [PubMed] [Google Scholar]
  • 9. Arnolo JMO, Braunwald E, Sandon T, Kloner RA: Inotropic stimulation of reperfused myocardium with dopamine: Effects on infarct size and myocardial function. J Am Coll Cardiol 1985; 6: 1026–1034. [DOI] [PubMed] [Google Scholar]
  • 10. Piérard LA, deLandsheere CM, Berthe C, Rigo P, Kulbertus HE: Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: Comparison with positron emission tomography. J Am Coll Cardiol 1990; 15: 21–1031. [DOI] [PubMed] [Google Scholar]
  • 11. Barilla F, Gheorghiade M, Alam M, Khaja F, Goldstein S: Low dose dobutamine in patients with acute myocardial infarction identifies viable but not contractile myocardium and predicts the magnitude of improvement in wall motion abnormalities in response to coronary revascularization. Am Heart J 1991; 122: 1522–1531. [DOI] [PubMed] [Google Scholar]
  • 12. Smart CS, Sawado S, Ryan T, Segar D, Alherton L, Berkovitz K, Bourdillon P, Feigenbaum H: Low dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993; 88: 405–415. [DOI] [PubMed] [Google Scholar]
  • 13. Gruppo Italiano per lo Studio delta Streptochinasi nell' Infarto Miocardico (GISSI) : Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1: 397–401. [PubMed] [Google Scholar]
  • 14. Tibbits PA, Evaul JE, Goldstein RE, Boccuzzi SJ, Therneau TM, Parker R, Wong D, and The Multicenter Post Infarction Research Group : Serial acquisition of data to predict one year mortality after acute myocardial infarction. Am J Cardiol 1987; 60: 451–455. [DOI] [PubMed] [Google Scholar]
  • 15. White HD, Norris RM, Brown MA: Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. N Engl J Med 1987; 317: 850–855. [DOI] [PubMed] [Google Scholar]
  • 16. Sheehan FH, Doerr R, Schmitdt WG: Early recovery of left ventricular function after thrombolytic therapy for acute myocardial infarction. An important determinant of survival. J Am Coll Cardiol 1988; 12: 289–300. [DOI] [PubMed] [Google Scholar]
  • 17. Res JCJ, Simoons ML, Van der Wall EE, Van Eeinge MJ, Vermeer F, Verheugt FWA, Serruys PW, Roos JP: Long term improvement in global left ventricular function after early thrombolytic treatment in acute myocardial infarction: Report of a randomized multicenter trial of intracoronary streptokinase in acute myocardial infarction. Br Heart J 1986; 65: 414–421. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES